University of Ioannina
Μελέτη των μηχανισμών δράσης συμπλόκων μετάλλων με κυτταροτοξική δράση
Abstract
dc:descriptionChemotherapy is a major field of cancer therapy, although the drugs used as chemotherapeutic agents show great selectivity and important side effects. Therefore, the research for new anticancer drugs is urgent. Ever since cisplatinum was introduced in oncology, many non conventional platinum compounds and non platinum metal complexes was designed and tested. Among them, organotin derivatives have shown high cytotoxicity and were found to be active against a large variety of tumors in vivo and in vitro. In this PhD thesis we examined the cytotoxic effects of novel organotin compounds (IV) with ortho- and para-hydroxybenzoic acid against several cancer cell lines, the mechanism of cellular death caused by these complexes and the in vivo effects of these complexes in regard of their toxicity and anticancer activity in tumor bearing wistar rats. The organotin complexes that was tested were of formulae [R₃Sn(HL)], (where HL= o-H2BZA and R = Ph- (1) or R= n-Bu- (3), or HL= p-H2BZA and R = Ph- (2) or R= n-Bu- (4)) and [R₂Sn(HL)₂] (where HL= o-H2BZA and R= n-Bu- (5)). In order to answer to these questions we used MTT assay, colony efficiency assay and flow cytometry. Furthermore, we tested the acute and subacute toxicity and the antitumor activity of complex 1 in tumor bearing wistar rats. In vitro experiments showed that all the tested organotin (IV) complexes show important cytotoxic activity (in the range of nM) in several cancer cell lines (LMS, HeLa, MCF-7, U2Os) with minor effects against MRC-5 cells (normal lung fibroblasts). Complexes 1-4 seem to inhibit the formation of colonies whereas all complexes cause apoptotic cellular death. In vivo experiments showed neurotoxicity, hepatotoxicity, kidney and lung toxicity after a single intraperitoneal injection of the complex 1, but only mild kidney damage during the study of subacute toxicity of this complex. Moreover, complex 1 at doses 1mg/kg/day managed to prolong median survival time (T/C% = 217,72%) and reduce tumor weight (TWI% = 60,16%) when given in tumor bearing wistar rats. This action was confirmed during the pathologoanatomic analysis with the tumor appearing necrosis of about 70-80%. Metastatic sites seem to be resistant to the complex. Therefore, we could come to the conclusion that all the complexes that were tested showed important cytotoxic effect in vitro, while complex 1 showed important anticancer effect in vivo with mild side effects and therefore it could be used as a chemotherapeutic agent.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agiorgiti, Maria
- Αγιοργίτη, Μαρία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35125